Neogenomics Inc
NASDAQ:NEO

Watchlist Manager
Neogenomics Inc Logo
Neogenomics Inc
NASDAQ:NEO
Watchlist
Price: 16.9 USD 2.24%
Market Cap: 2.2B USD
Have any thoughts about
Neogenomics Inc?
Write Note

Relative Value

The Relative Value of one NEO stock under the Base Case scenario is 20.15 USD. Compared to the current market price of 16.9 USD, Neogenomics Inc is Undervalued by 16%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NEO Relative Value
Base Case
20.15 USD
Undervaluation 16%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
71
vs Industry
55
Median 3Y
3.2
Median 5Y
4.2
Industry
4.1
Forward
3.2
vs History
vs Industry
100
Median 3Y
-20.8
Median 5Y
-17.9
Industry
32.7
Forward
170.3
vs History
30
vs Industry
100
Median 3Y
-37.7
Median 5Y
-17.2
Industry
22.1
vs History
vs Industry
Median 3Y
-26.2
Median 5Y
-11.6
Industry
33.6
vs History
57
vs Industry
45
Median 3Y
2
Median 5Y
2.4
Industry
2.6
vs History
77
vs Industry
47
Median 3Y
3.3
Median 5Y
4.4
Industry
3.9
Forward
3.2
vs History
84
vs Industry
44
Median 3Y
8.2
Median 5Y
11.4
Industry
8.6
vs History
vs Industry
4
Median 3Y
-57.9
Median 5Y
-15.2
Industry
18.5
Forward
54.9
vs History
vs Industry
Median 3Y
-19.7
Median 5Y
-20.3
Industry
23.7
Forward
-24.8
vs History
30
vs Industry
100
Median 3Y
-40.1
Median 5Y
-18.2
Industry
21.4
vs History
vs Industry
Median 3Y
-34.3
Median 5Y
-53.4
Industry
28.8
vs History
68
vs Industry
50
Median 3Y
1.6
Median 5Y
1.9
Industry
2.4

Multiples Across Competitors

NEO Competitors Multiples
Neogenomics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Neogenomics Inc
NASDAQ:NEO
2.2B USD 3.4 -27.8 -157.9 -24.6
US
PerkinElmer Inc
LSE:0KHE
1.2T USD 448.2 4 796.2 1 513.6 3 225.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
200.4B USD 4.7 32.7 21.2 30.4
US
Danaher Corp
NYSE:DHR
165.4B USD 7.8 42.5 26.7 40.1
KR
Samsung Biologics Co Ltd
KRX:207940
66.8T KRW 15.3 63.4 34.3 49.4
CH
Lonza Group AG
SIX:LONN
38.4B CHF 5.7 67 45.3 45.3
US
Agilent Technologies Inc
NYSE:A
38.5B USD 5.9 29.9 22.3 25.9
US
IQVIA Holdings Inc
NYSE:IQV
35.9B USD 2.4 25.7 14.1 21.5
US
Mettler-Toledo International Inc
NYSE:MTD
26.8B USD 7.1 33.7 24.1 26.9
US
West Pharmaceutical Services Inc
NYSE:WST
24.1B USD 8.3 47.9 32.3 40.6
CN
WuXi AppTec Co Ltd
SSE:603259
164.4B CNY 4.3 20.4 14.8 14.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Neogenomics Inc
NASDAQ:NEO
Average EV/EBITDA: 174.9
Negative Multiple: -157.9
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 513.6
23%
66.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
21.2
19%
1.1
US
Danaher Corp
NYSE:DHR
26.7
22%
1.2
KR
Samsung Biologics Co Ltd
KRX:207940
34.3
57%
0.6
CH
Lonza Group AG
SIX:LONN
45.3
36%
1.2
US
Agilent Technologies Inc
NYSE:A
22.3
34%
0.7
US
IQVIA Holdings Inc
NYSE:IQV
14.1
32%
0.4
US
Mettler-Toledo International Inc
NYSE:MTD
24.1
16%
1.5
US
West Pharmaceutical Services Inc
NYSE:WST
32.3
16%
2
CN
WuXi AppTec Co Ltd
SSE:603259
14.8
52%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Neogenomics Inc
NASDAQ:NEO
Average EV/EBIT: 352
Negative Multiple: -24.6
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
3 225.5
130%
24.9
US
Thermo Fisher Scientific Inc
NYSE:TMO
30.4
57%
0.5
US
Danaher Corp
NYSE:DHR
40.1
59%
0.7
KR
Samsung Biologics Co Ltd
KRX:207940
49.4
76%
0.6
CH
Lonza Group AG
SIX:LONN
45.3
37%
1.2
US
Agilent Technologies Inc
NYSE:A
25.9
42%
0.6
US
IQVIA Holdings Inc
NYSE:IQV
21.5
70%
0.3
US
Mettler-Toledo International Inc
NYSE:MTD
26.9
22%
1.2
US
West Pharmaceutical Services Inc
NYSE:WST
40.6
13%
3.2
CN
WuXi AppTec Co Ltd
SSE:603259
14.8
23%
0.6

See Also

Discover More
Back to Top